LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Akari Therapeutics (NASDAQ: AKTX)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ AKTX Akari Therapeutics
Patel Samir Rashmikant / director
12/02/2024
Buy
$0.0012
419.29M
$503K
5.24B
NASDAQ AKTX Akari Therapeutics
Patel Samir Rashmikant / director
12/02/2024
Buy
$0.0011
419.29M
$461K
419.29M
NASDAQ AKTX Akari Therapeutics
Patel Samir Rashmikant / director
11/30/2024
Buy
$0.0006
162.60M
$98K
162.60M
NASDAQ AKTX Akari Therapeutics
Prudo-Chlebosz Raymond / director
12/02/2024
Buy
$0.0012
419.29M
$503K
4.08B
NASDAQ AKTX Akari Therapeutics
Prudo-Chlebosz Raymond / director
12/02/2024
Buy
$0.0011
419.29M
$461K
419.29M
NASDAQ AKTX Akari Therapeutics
Patel Sandip I / director
11/14/2024
Sell
$0.0014
234.80M
$329K
0
NASDAQ AKTX Akari Therapeutics
Neal James R / director
11/14/2024
Sell
$0.001
19.57M
$20K
0
NASDAQ AKTX Akari Therapeutics
Neal James R / director
11/14/2024
Sell
$0.0014
293.50M
$411K
0
NASDAQ AKTX Akari Therapeutics
Huh Hoyoung / director, 10 percent owner:
11/14/2024
Sell
$0.001
103.48M
$103K
0
NASDAQ AKTX Akari Therapeutics
Huh Hoyoung / director, 10 percent owner:
11/14/2024
Sell
$0.0014
704.40M
$986K
0
NASDAQ AKTX Akari Therapeutics
Patel Samir Rashmikant / director
10/31/2024
Buy
$0.0013
79.68M
$104K
79.68M

COPYRIGHT ©2023 HEALTH STOCKS HUB